San Mateo, CA
PrognomiQ aims to generate proteomic information with high accuracy, scale and speed. This proteomic data will be complemented with genomic, metabolomic and other health information to deliver first-in-class test products that enable early disease detection and treatment.
prognomiq.comThese are collections PrognomiQ is a part of. Click on the collection name to view similar companies.
Series D
$34,000,000
Series Unknown
$46,000,000
Series Unknown
$55,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on PrognomiQ.